| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gleason Todd R | Chief Executive Officer, Director | 5080 SPECTRUM DRIVE, SUITE 800E, ADDISON | /s/ Kiril Kovachev as Attorney-in-Fact for Todd Gleason | 09 Mar 2026 | 0001571235 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CECO | Common Stock | Tax liability | -3,557 | -0.87% | $52.53* | 407,278 | 07 Mar 2026 | Direct | F1 | |
| holding | CECO | Common Stock | 444 | 07 Mar 2026 | By first son | ||||||
| holding | CECO | Common Stock | 444 | 07 Mar 2026 | By second son | ||||||
| holding | CECO | Common Stock | 444 | 07 Mar 2026 | By third son | ||||||
| holding | CECO | Common Stock | 444 | 07 Mar 2026 | By daughter |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CECO | Stock Option (right to buy) | 316,902 | 07 Mar 2026 | Common Stock | 316,902 | $6.36 | Direct | F2 | |||||
| holding | CECO | Stock Option (right to buy) | 598,204 | 07 Mar 2026 | Common Stock | 598,204 | $12.72 | Direct | F2 | |||||
| holding | CECO | Stock Option (right to buy) | 25,446 | 07 Mar 2026 | Common Stock | 25,446 | $21.31 | Direct | F3 | |||||
| holding | CECO | Stock Option (right to buy) | 67,347 | 07 Mar 2026 | Common Stock | 67,347 | $23.50 | Direct | F4 | |||||
| holding | CECO | Restricted Stock Units | 225,000 | 07 Mar 2026 | Common Stock | 225,000 | Direct | F5, F6 | ||||||
| holding | CECO | Restricted Stock Units | 150,000 | 07 Mar 2026 | Common Stock | 150,000 | Direct | F5, F7 |
| Id | Content |
|---|---|
| F1 | Reflects shares withheld for net settlement to cover the tax liability for the vesting of restricted stock units. |
| F2 | The stock option vested in four installments beginning on June 6, 2021, and expires on June 6, 2027. |
| F3 | The stock option vests in three equal annual installments beginning on March 15, 2025, and expires on March 15, 2034. |
| F4 | The stock option vests in three equal annual installments beginning on March 17, 2026, and expires on March 17, 2035. |
| F5 | Represents performance-based restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Company's stock. |
| F6 | Conversion of restricted stock units to the Company's common stock will occur on July 5, 2027 assuming the reporting person is still employed by the Company and if the shares of the Company's common stock have achieved certain stock price targets over the course of the performance period. |
| F7 | Conversion of restricted stock units to the Company's common stock will occur on June 4, 2029 assuming the reporting person is still employed by the Company and if the shares of the Company's common stock have achieved certain stock price targets over the course of the performance period. |
Exhibit 24: Power of Attorney